Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial
General

Weekly Mashup – Edition 13

Capitalmind-Mashup-17122016.png

capitalmind-mashup-17122016
Capitalmind Mashup – a weekly newsletter to bring you a platter of publications over the past few days. All content shared here can be accessed by users except #Premium limited to only Capitalmind Premium Subscribers. Catch all the previous mashups here.
Hope you have a good time reading this Mashup. Do share your views in the comment section below!

#Charts

Foreign Investors Exit Government Debt In A Hurry, Sell 33,000 cr. In A Month

#Economy

Demonetization Impact : Industry Comments Part IV : Delayed Consumption?
The Market Stabilization Scheme And What It Means
RBI: 12.44 Lakh Crore From Old Notes is Back. And Bank Credit Growth Has Collapsed

Weekly Mashup – Edition 13#General:

On Slack: 1% = 40 Lakh Cases, Arbitrage Mutual Funds, Investor or Speculator, Irrational Thinking, Still Using Cash?
On Slack: Botched War on Cash, Chasing Trump’s Tail, Odd Lots, Taxation on Debt Funds, TCS EGM Drama, Tracking Hyperinflation, Value Investing

#Premium

Bond Baba: The Pecking Order is Capital Gains > Interest > Dividend

#Stocks

Crompton Greaves Cancels Sale of T&D Business
Alkem Laboratories & Divis Laboratories Receive Form 483 From US FDA
Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Sun Pharma’s Halol Facility

#Premium Unlocked

The Concept of Max Pain in Options
Bond Baba: Why Are There Two 10-Year Bonds With Different Yields?
Exiting Capital Mind Monsoon Portfolio – Returns 20% in 4 Months
Macronomics: The Strange Case of the Highest LIBOR Since 2009
Portfolio: Exiting Aarti Drugs and GSFC From Momentum
StratOptions: IV spike post Surgical Strikes helps us score a quick 2.63%
Using Ratio Spreads to trade earnings: A live-example on INFY
Love it or hate it, do leave us with your reviews in the comment section below!